Operates a consortium of commonly-owned but independent biotech companies offering an innovative and cost-effective approach to start-ups in the life sciences industry. Synergenics provides member companies with financial support, shared laboratory facilities and experienced management and administrative services, creating true economies of scale. In addition, the Synergenics concept provides an open and collaborative environment among member companies that allows a free exchange of ideas and technology, while protecting each companys defined proprietary domains.Participant companies include: Numera Advanced personal health management system for improving the health of populations. Real time data capture from virtually any electronic home monitoring/metric device; provides Internet and mobile access to a secure, interactive and shareable record for individuals, health professionals, payers and other healthcare companies (aggregated and anonymous data.) Emphasis on health maintenance and chronic condition management. Global markets. Relia Diagnostic Systems Rapid, sensitive and quantitative point-of-care diagnostics for infectious disease, cardiac disease and a variety of other indications suitable for the POC market. Ventria Bioscience Cost-effective production of human proteins in cereal grains/rice. Products for antibody/protein production market, and orally active human therapeutic proteins. Synco Bio Partners Development and moderate scale GMP manufacturing of Therapeutic proteins, antibodies and vaccines. Humabs Human monoclonal antibodies isolated from cloned human memory B cells selected for activity against infectious diseases, cancer and certain other debilitating diseases. Pathologica Small molecule drugs that target a defined class of inflammatory macrophages involved in production of cytokines , and etiology of a wide range of pathologies. Picobella Diagnostic and therapeutic products based on the comprehensive identification and characterization of oncogenes/tumor suppressors (both protein, and RNA genes). Poetic Genetics Gene therapy based on a proprietary integrase which inserts genetic elements irreversibly into transcriptionally active sites on chromosomes. BioEnergenix Drug development involving a novel therapeutic target controlling obesity and diabetes.
